|
CA2007364A1
|
|
Gene sequences encoding modified residues situated in the protease domain of tpa
|
|
AU3064989A
|
|
Modified gene sequences encoding modified tpa and products therefrom
|
|
EP0398962A1
|
|
Rearranged tissue plasminogen activators and method for producing same
|
|
WO9002757A1
|
|
Heteropolymeric protein
|
|
AU2262688A
|
|
Improved protein c molecules and method for making and activating same
|
|
EP0380508A1
|
|
Improved protein c molecules and method for making and activating same
|
|
AU1788988A
|
|
Substances for detecting bloodclots
|
|
AU1801888A
|
|
Therapeutic enzymes
|
|
US4908318A
|
|
Nucleic acid extraction methods
|
|
EP0255320A2
|
|
Production of proteins in myeloma cells
|
|
EP0232085A2
|
|
Campylobacter probe
|
|
US4717670A
|
|
Porcine beta FSH
|
|
US4954437A
|
|
Cell encoding recombinant human erythropoietin
|
|
JPS6261969A
|
|
Synthesis of acridinium ester
|
|
JPS62130690A
|
|
Human uterus plasminogen activator produced by recombinant dna
|
|
JPS6239598A
|
|
Labelled nucleic acid
|
|
EP0192679A1
|
|
Yeast cloning vehicles.
|
|
WO8600637A1
|
|
Yeast cloning vehicle
|
|
CA1272972A
|
|
Vector encoding hepatitis b surface antigen
|
|
US4923805A
|
|
Fsh
|
